MOS
APTO

MGO One Seven’s Aptose Biosciences, Inc. APTO Stock Holding History

MGO One Seven’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$19K Hold
13
– – 0.01% 894
2017
Q4 		$13K Buy
+13
New +$10K 0.01% 1009

Other funds holding APTO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

MGO One Seven's APTO Position: Q1 2018 in Review

MGO One Seven held its Aptose Biosciences, Inc. (APTO) position steady in Q1 2018 at 13 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #894.

MGO One Seven first reported a position in APTO in Q4 2017 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2018.

  • MGO One Seven held 13 shares of Aptose Biosciences, Inc. worth $19K as of Q1 2018.
  • MGO One Seven left its Aptose Biosciences, Inc. share count unchanged in Q1 2018.
  • Aptose Biosciences, Inc. made up 0.01% of MGO One Seven's portfolio in Q1 2018, its #894 holding.
  • MGO One Seven first reported a position in Aptose Biosciences, Inc. in Q4 2017 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.